The unregulated commercialization of stem cell treatments: a global perspective.

@article{Sipp2011TheUC,
  title={The unregulated commercialization of stem cell treatments: a global perspective.},
  author={Douglas Sipp},
  journal={Frontiers of medicine},
  year={2011},
  volume={5 4},
  pages={348-55}
}
Research into the biological properties and clinical potential of stem cells has spurred strong public investment, industry development, media coverage, and patient interest in recent years. To date, however, few clinical applications of demonstrated safety and efficacy have been developed with the exception of uses of hematopoietic stem cells in the treatment of diseases of the blood and immune systems. This lack of an evidence basis notwithstanding, hundreds of companies and private clinics… CONTINUE READING